J Fleury
Papers
1
Total Citations
16
H-Index
1
About
Dr. J. Fleury is a distinguished hematologist-oncologist whose research has significantly advanced the understanding of myeloproliferative neoplasms (MPNs) and their molecular complexities. Her seminal work focuses on the intersection of Philadelphia chromosome-positive chronic myeloid leukemia (CML) and JAK2-mutated MPNs, particularly the phenomenon of thrombocytosis emerging during targeted therapy. In her highly cited 2009 study (16 citations), Dr. Fleury demonstrated that a rising platelet count in CML patients achieving molecular remission on imatinib can unmask an underlying JAK2V617F-positive MPN—a critical diagnostic insight that has reshaped clinical monitoring protocols. This discovery underscores her expertise in molecular hematopathology and the nuanced management of dual-driver mutations. Dr. Fleury’s contributions have provided a framework for distinguishing treatment-related side effects from concurrent clonal disorders, directly impacting patient care strategies. Her work remains a cornerstone for researchers exploring clonal evolution and resistance mechanisms in MPNs, with her findings frequently referenced in guidelines for managing atypical responses to tyrosine kinase inhibitors. Through precise clinical observation and molecular correlation, Dr. Fleury has illuminated a previously unrecognized pathway in hematologic malignancies, cementing her role as a key figure in translational hematology.
Research Focus
Key Achievements
Top Papers
- 1